the first ever Molecular bacterial load assay (MBLA) stakeholders conference was held at the University of St Andrews, 11th – 13th June 2018.
Experts from around the world are gathered in St Andrews to learn how to dramatically cut the time needed to diagnose tuberculosis to save hundreds of thousands of lives.
Dr. Wilber Sabiiti recently presented a paper at the Keystone Symposia on Translation of tuberculosis research into policy and practice.
Dr. Wilber Sabiiti spent several days with the Porton Down PHE tuberculosis (TB) research team training them and optimising their Real-time PCR platform QuantiStudio TM Vii 6 and 7 Flex to perform Molecular bacterial load assay (MBLA).
Dr. Wilber Sabiiti recently presented some of his work at the UARC-TLD.
Hosted as part of the 6th East African Health and Scientific Research Conference and International trade fair the symposium was co-chaired by Dr. Wilber Sabiiti and Dr. Helen Meme of Kenya Medical Research Institute (KEMRI).
Dr Wilber Sabiiti has recently given a series of talks and training in different African countries showcasing the advantages of the molecular bacterial load assay (MBLA) and TWENDE work on developing model for rapid uptake of health research innovations into policy and practice.
TWENDE is building a model to increase effectiveness of implementing health research innovations. Dr. Wilber Sabiiti, the co-ordinator of TWENDE Consortium has recently completed the TWENDE site monitoring visits in Kenya, Tanzania and Uganda and witnessed the great progress made.
Professor Stephen Gillespie, Sir James Black Chair of Medicine, has been interviewed about tuberculosis for the Lancet Respiratory Medicine World TB day issue that is now available.
Dr Wilber Sabiiti and Dr Derek Sloan recently represented the University of St Andrews at the 8th EDCTP forum.
- Page 1 of 2